Major Advancements in MASH Management

Rush University Medical Center

S. Janardhan

MAFLD: What Is It?

Houston Methodist

D. Victor

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

New Therapy for Fatty Liver Disease

Washington University in St. Louis

K. Korenblat

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

MASLD Updates Early 2025

Adrian Lindsey

Primary Biliary Cholangitis: State of the Art in 2024

MUSC Health

K. Kowdley

Updates in Cholestatic Liver Disease: PBC and PSC

University of Colorado Department of Medicine

A. Kalra

Fatty Liver Disease: When to Refer?

Yale School of Medicine

MASLD for the Non-Hepatologist: Insights from ADA Guidelines

Washington University in St. Louis

K. Williams

NAFLD: Updates in Management

UChicago Medicine

M. E. Rinella

Caring for the Post Liver Transplant Patient in the Primary Care Set…

University of Colorado Department of Medicine

B. Henderson, M. O'Meara

Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD/MASH…

Pennsylvania Society of Gastroenterology

M. Lagarde

Updates on Management of NASH

Pennsylvania Society of Gastroenterology

T. Singh

End to End GI Pathology (and the Liver, Too!)

UCSF School of Medicine

J. (J. P.) Grenert

Cystic Duct Disorders

Cleveland Clinic - Digestive Disease Institute

H. Siddiki

Non-Alcoholic Fatty Liver Disease: Where Are We in 2023?

Houston Methodist

N. Gunn

Heart and Liver Interactions

Houston Methodist DeBakey Heart and Vascular Center

S. Adeel Ahsan